EMA — authorised 31 December 2009
- Application: EMEA/H/C/000635
- Marketing authorisation holder: Alcon Laboratories (U.K.) Limited.
- Local brand name: Retaane
- Status: withdrawn
EMA authorised Retaane on 31 December 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 31 December 2009.
Alcon Laboratories (U.K.) Limited. holds the EU marketing authorisation.